H. saimiri tyrosine-kinase interacting protein inhibits Tat function: A prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells

Virology

Volumn 352, Issue 2, 2006, Pages 253-267

  Raymond, Andrea D ^a   Hasham, Muneer ^a   Tsygankov, Alexander Y ^a   Henderson, Earl E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; HVS; Intrinsic immunity; Stats 1 and 3; Tat; Tip

Indexed keywords

GAMMA INTERFERON; PROTEIN KINASE LCK; PROTEIN P68; PROTEIN TYROSINE KINASE; RNA; STAT1 PROTEIN; STAT3 PROTEIN; TRANSACTIVATOR PROTEIN; TYROSINE KINASE INTERACTING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; ENZYME ACTIVATION; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPETENT CELL; LONG TERMINAL REPEAT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROVIRUS; T LYMPHOCYTE; TRANSACTIVATION; VIRUS ACTIVATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; EIF-2 KINASE; GENE PRODUCTS, TAT; HERPESVIRUS 2, SAIMIRIINE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MONOCYTES; PHOSPHOPROTEINS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; TRANSFORMATION, GENETIC; U937 CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

EID: 33747035823     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.016     Document Type: Article

References (55)

1. Ancuta P., Kunstman K.J., Autissier P., Zaman T., Stone D., Wolinsky S.M., and Gabuzda D. CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344 (2006) 267-276
2. Babst M., Odorizzi G., Estepa E.J., and Emr S.D. Mammalian tumor susceptibility gene 101(TSG01) and the yeast homologue, Vsp23p, both function in late endosomal trafficking. Traffic 1 (2000) 248-258
3. Bednarik D.P., Cook J.A., and Pitha P.M. Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. EMBO 9 (1990) 1157-1164
4. Bieniasz P.D., Grdina T.A., Bogerd H.P., and Cullen B.R. Recruitment of cylcinT1/p-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7791-7796
5. Biesinger B., Tsygankov A.Y., Fickenscher H., Emmrich R., Fleckenstein B., Bolen J.B., and Broker B.M. The product of the Herpesvirus saimiri open reading frame 1 (Tip) interacts with T-cell specific kinase p56Lck in transformed cells. J. Biol. Chem. 270 (1995) 4729-4734
6. Brand S.R., Kobayashi R., and Matthews M.B. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the Interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272 (1997) 8388-8395
7. Brooks D.G., Arlen P.A., Gao L., Kitchen C.M., and Zack J.A. Identification of T-cell signaling pathways that stimulate latent HIV in primary cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12955-12960
8. Cai R., Carpick B., Chun R.F., Jeang K.T., and Williams B.R. HIV Tat inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch. Biochem. Biophys. 373 (2000) 361-367
9. Caselli E., Galvan M., Cassai E., Caruso A., Sighinolfi L., and Di Luca D. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood 106 (2005) 2790-2797
10. Chehimi J., Starr S.E., Frank I., D'Andrea A., Ma X., Macgregor R.R., Sennelier J., and Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179 (1994) 1361-1366
11. Darnell Jr. J.E., Kerr I.M., and Stark G.R. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
12. Dong B., and Silverman R.H. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J. Biol. Chem. 270 (1995) 4133-4137
13. Dong B., Xu L., Zhou B., Hassel B.A., Lee X., Torrence P.F., and Silverman R.H. Intrinsic molecular activities of the interferon induced 2-5A-dependent RNase. J. Biol. Chem. 269 (1994) 14153-14158
14. Douaisi M., Dussart S., Courcoul M., Bessou G., Vigne R., and Decroly E. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles. Biochem. Biophys. Res. Commun. 321 (2004) 566-573
15. Emiliani S., Van Lint C., Fischle W., Paras Jr. P., Ott M., Brady J., and Verdin E. A point mutation in the HIV Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6377-6381
16. Feinberg M.B., Baltimore D., and Frankel A.D. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4045-4049
17. Folks T.M., Clouse K.A., Justement J., Rabson A., Duh E., Kehrl J.H., and Fauci A.S. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 2365-2368
18. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., and Sundquist W.I. TSG101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 (2001) 55-65
19. Gil J., and Esteban M. Induction of apoptosis by the dsRNA-dependent protein kinase(PKR): mechanism of action. Apoptosis 5 (2000) 107-114
20. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., and Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 113 (2003) 803-809
21. Hartley D.A., and Cooper G.M. Direct binding and activation of STAT transcription factors by the herpesvirus saimiri protein tip. J. Biol. Chem. 275 (2000) 16925-16932
22. Hartley D.A., Hurley T.R., Hardwick J.S., Lund T.C., Medveczky P.G., and Sefton B.M. Activation of lck tyrosine protein kinase by the binding of tip protein of herpesvirus saimiri in the absence of regulatory tyrosine phosphorylation. J. Biol. Chem. 274 (1999) 20056-20059
23. Hasham M.G., and Tsygankov A.Y. Tip, an Lck-interacting protein of Herpesvirus saimiri, causes Fas- and Lck-dependent apoptosis in T-lymphocytes. Virology 320 (2004) 313-329
24. Hatziiannou T., Perez-Caballero D., Yang A., Cowan S., and Bieniasz P.D. Retrovirus resistance factors Ref1 and Lv1 are species-specific variant of Trim5α. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10774-10779
25. Henderson E.E., Tsygankov A.Y., Merlo J.J., Romano G., and Guan M. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and Tip. Virology 264 (1999) 125-133
26. Horvath C.M., and Darnell Jr. J.E. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J. Virol. 70 (1996) 647-650
27. Kannangara S., DeSimone J.A., and Pomerantz R.J. Attenuation of HIV-1 infection by other microbial agents. J. Infect. Dis. 192 (2005) 1003-1009
28. Katzmann D.J., Babst M., and Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex. ESCRT-I. 106 (2001) 145-155
29. Kerr I.M., and Brown R.E. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme from interferon treated cells. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 256-260
30. Kjellen P., Amdjadi K., Lund T.C., Medveczky P.G., and Sefton B.M. The Herpesvirus saimiri tip484 and 488 proteins both stimulate lck tyrosine kinase activity in vitro and in vivo. Virology 297 (2002) 281-288
31. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saib A., and Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 308 (2005) 557-560
32. Lund T., Medveczky M.M., Geck P., and Medveczky P.G. A Herpesvirus saimiri protein required for interleukin-2 independence is associated with the membrane of transformed T cells. J. Virol. 69 (1995) 4495-4499
33. Lund T., Garcia R., Medveczky M.M., Jove R., and Medveczky P.G. Activation of STAT transcription factors by herpesvirus saimiri Tip-484 requires p56lck. J. Virol. 71 (1997) 6677-6682
34. Lund T., Medveczky M.M., and Medveczky P.G. Herpesvirus saimiri Tip-484 membrane protein markedly increases p56lck activity in T-cells. J. Virol. 71 (1997) 378-382
35. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., and Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 (2003) 99-103
36. McMillan N.A., Chun R.F., Siderovski D.P., Galabru J., Toone W.M., Samuel C.E., Mak T.W., Hovanessian A.G., Jeang K.T., and Williams B.R. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213 (1995) 413-424
37. Merlo J.J., Romano G., Gordon S.S., Feshchenko E.A., Peng G., Henderson E.E., and Tsygankov A.Y. Human T cells transduced by a retroviral vector to express Herpesvirus saimiri protein TIP and STPC. Anticancer Res. 18 (1998) 125-133
38. Meurs E.F., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R., and Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62 (1990) 379-390
39. Meyaard L., Hovenkamp E., Keet I.P., Hooibrink B., de Jong I.H., Otto S.A., and Miedema F. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J. Immunol. 157 (1996) 2712
40. Pomerantz R.J., Trono D., Feinberg M.B., and Baltimore D. Cells non-productively infected with HIV-1 exhibit an aberrant pattern of viral expression: a molecular model for latency. Cell 61 (1990) 1271-1276
41. Raymond A.D., Hasham M.G., Tsygankov A.Y., and Henderson E.E. Herpesvirus saimiri-encoded Tip and StpC modulate human immunodeficiency virus type 1 replication on T cell lines and lymphocytes independently of viral tropism. Virology 324 (2004) 60-66
42. Rice A.P., Duncan R., Hershey J.W., and Kerr I.M. Double-stranded RNA-dependent protein kinase and 2-5 A system are both activated in interferon-treated encephalomyocarditis virus-infected HeLa cells. J. Virol. 54 (1985) 894-898
43. Samuel C.E. Mechanism of interferon action. Phosphorylation of protein synthesis initiation factor eIF2 in interferon treated human cells by a ribosome-associated protein kinase possessing site-specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 600-604
44. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
45. Samuel C.E., Duncan R., Knutson G.S., and Hershey J.W. Mechanism of interferon action: increased phosphorylation of protein synthesis initiation factor eIF-2 alpha in interferon-treated, reovirus-infected mouse L929 fibroblasts in vitro and in vivo. J. Biol. Chem. 259 (1984) 13451-13457
46. Schmitz C., Marchant D., Neil S.J., Aubin K., Reuter S., Dittmar M.T., and McKnight A. Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J. Virol. 78 (2004) 2006-2016
47. Sheehy A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418 (2002) 646-650
48. Shuai K., Horvath C.M., Huang L.H., Qureshi S.A., Cowburn D., and Darnell Jr. J.E. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phophotyrosyl peptide interactions. Cell 76 (1994) 821-828
49. Straus D.B., and Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70 (1992) 585-593
50. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature 427 (2004) 848-853
51. Takada N., Sanda T., Okamoto H., Yang J.P., Asamitsu K., Sarol L., Kimura G., Uranishi H., Tetsuka T., and Okamoto T. RelA-associated inhibitor blocks transcription of human immunodeficiency virus type1 by inhibiting NF-κB and SP1 actions. J. Virol. 76 (2002) 8019-8030
52. Ullum H., Cozzi Lepri A., Bendtzen K., Victor J., Gotzsche P.C., Phillips A.N., Skinhoj P., and Klarlund Pedersen B. Low production of interferon gamma is related to disease production in HIV infection: evidence from a cohort of 347 HIV-infected individuals. AIDS Res. Hum. Retroviruses 13 (1997) 1039-1046
53. Vella C., Fickenscher H., Atkins C., Penny M., and Daniels R. Herpesvirus saimiri-immortalized human T-cells support long, high titered replication of human immunodeficiency virus types 1 and 2. J. Gen. Virol. 78 (1997) 1405-1409
54. Weiss A. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73 (1993) 209-212
55. Weiss A., and Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell 76 (1994) 263-274